GENELUX CORP (GNLX) Stock News

USA - Nasdaq - NASDAQ:GNLX - US36870H1032 - Common Stock

4.27 USD

+0.17 (+4.15%)

Last: 12/17/2025, 2:04:43 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

GNLX Latest News, Press Relases and Analysis

All

Press Releases

21 days ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference

21 days ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Benzinga - Mentions: HAE WORX GDTC VTVT ...

12 Health Care Stocks Moving In Thursday's Intraday Session

a month ago - By: Genelux Corporation

Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

a month ago - By: Genelux Corporation

Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

2 months ago - By: Benzinga - Mentions: MOH BIOA ITGR ARMP ...

12 Health Care Stocks Moving In Thursday's Intraday Session

4 months ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

4 months ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

4 months ago - By: Genelux Corporation

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

4 months ago - By: Genelux Corporation

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

5 months ago - By: Genelux Corporation

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

5 months ago - By: Genelux Corporation

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

7 months ago - By: Zacks Investment Research

Genelux Corporation (GNLX) Upgraded to Buy: Here's What You Should Know

7 months ago - By: Genelux Corporation

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

7 months ago - By: Genelux Corporation

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

8 months ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

8 months ago - By: Zacks Investment Research

Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?

9 months ago - By: Genelux Corporation

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

9 months ago - By: Genelux Corporation

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

9 months ago - By: Genelux Corporation

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

9 months ago - By: Genelux Corporation

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

9 months ago - By: Genelux Corporation

Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

9 months ago - By: Genelux Corporation

Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease

9 months ago - By: Genelux Corporation

Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease

9 months ago - By: Genelux Corporation

Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

11 months ago - By: Genelux Corporation

Genelux Corporation Announces New Chief Financial Officer

11 months ago - By: Genelux Corporation

Genelux Corporation Announces New Chief Financial Officer

a year ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright

a year ago - By: Genelux Corporation

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright

a year ago - By: Genelux Corporation

Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates

a year ago - By: Genelux Corporation

Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates

a year ago - By: Genelux Corporation

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference

a year ago - By: Genelux Corporation

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference

a year ago - By: Genelux Corporation

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer